Gregory Mark Weinhoff

Gregory Mark Weinhoff

Director of Finance/CFO bei CENTESSA PHARMACEUTICALS PLC

Vermögen: 3 Mio $ am 31.03.2024

53 Jahre
Health Technology
Finance
Health Services

Profil

Gregory Mark Weinhoff is the founder of Ella Health, Inc. (founded in 2011) and Arvelle Therapeutics International GmbH (founded in 2019).
He holds the title of Director at Ella Health, Inc. and Chief Financial & Business Officer, Director at Arvelle Therapeutics International GmbH.
He was also the founder of Arvelle Therapeutics BV (founded in 2019) and held the title of Chief Financial & Business Officer at the company from 2019 to 2021.
Dr. Weinhoff's current job(s) include being a Venture Partner at Healthinvest Equity Partners and Chief Financial & Accounting Officer at Centessa Pharmaceuticals Plc.
His former job(s) include being the Chief Executive Officer & Director at Amicus Therapeutics, Inc. from 2002 to 2009, Executive Chairman at Resolvyx Pharmaceuticals, Inc., Director at LuMend, Inc., Director at Concerto Health Services, Inc., Director at PrimeraDx, Inc., Director at Celula, Inc., Director at VaxInnate Corp., Senior Associate at J.H.
Whitney Capital Partners, LLC from 2000 to 2001, Financial Analyst at Morgan Stanley & Co. LLC, Senior Associate at W.G.
Shaheen & Associates Ltd., Chief Financial & Accounting Officer at Sio Gene Therapies, Inc. from 2018 to 2019, Chief Financial Officer at Axovant Sciences, Inc. from 2015 to 2019, and Vice President & Partner at CHL Healthcare Partners LLC from 2012 to 2013.
Dr. Weinhoff's education history includes a doctorate degree from Harvard Medical School, an MBA degree from Harvard Business School, and an undergraduate degree from Harvard College.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.03.2024 265 111 ( 0,29% ) 3 Mio $ 31.03.2024

Aktive Positionen von Gregory Mark Weinhoff

UnternehmenPositionBeginn
CENTESSA PHARMACEUTICALS PLC Director of Finance/CFO 01.03.2021
Private Equity Investor -
Founder 01.01.2019
Alle aktiven Positionen von Gregory Mark Weinhoff

Ehemalige bekannte Positionen von Gregory Mark Weinhoff

UnternehmenPositionEnde
Founder 01.02.2021
Director of Finance/CFO 30.06.2019
SIO GENE THERAPIES INC. Director of Finance/CFO 30.06.2019
AMICUS THERAPEUTICS, INC. Chief Executive Officer 07.01.2009
Corporate Officer/Principal 01.01.2001
Sehen Sie sich die Erfahrung von Gregory Mark Weinhoff im Detail an

Ausbildung von Gregory Mark Weinhoff

Harvard Medical School Doctorate Degree
Harvard Business School Masters Business Admin
Harvard College Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Gregory Mark Weinhoff im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
AMICUS THERAPEUTICS, INC.

Health Technology

CENTESSA PHARMACEUTICALS PLC

Health Technology

Private Unternehmen16

Health Technology

Finance

Health Services

Health Technology

Health Technology

Health Services

Finance

Finance

Health Services

Health Technology

Finance

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Gregory Mark Weinhoff